A citation-based method for searching scientific literature

Anne I Hagen, Kjell Arne Kvistad, Lovise Maehle, Marit Muri Holmen, Hildegunn Aase, Bodil Styr, Anita Vabø, Jaran Apold, Per Skaane, Pål Møller. Breast 2007
Times Cited: 117



Madeleine Tilanus-Linthorst, Leon Verhoog, Inge-Marie Obdeijn, Karina Bartels, Marian Menke-Pluymers, Alexander Eggermont, Jan Klijn, Hanne Meijers-Heijboer, Theo van der Kwast, Cecile Brekelmans. Int J Cancer 2002
Times Cited: 127




List of shared articles



Times cited


BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations.
Mai Elezaby, Brittany Lees, Katherine E Maturen, Lisa Barroilhet, Kari B Wisinski, Sarina Schrager, Lee G Wilke, Elizabeth Sadowski. Radiology 2019
14

Breast MRI as an adjunct to mammography for breast cancer screening in high-risk patients: retrospective review.
Antony Raikhlin, Belinda Curpen, Ellen Warner, Carrie Betel, Barbara Wright, Roberta Jong. AJR Am J Roentgenol 2015
29

MRI breast screening in high-risk women: cancer detection and survival analysis.
D Gareth Evans, Nisha Kesavan, Yit Lim, Soujanye Gadde, Emma Hurley, Nathalie J Massat, Anthony J Maxwell, Sarah Ingham, Rosalind Eeles, Martin O Leach,[...]. Breast Cancer Res Treat 2014
74

Screening MR imaging versus screening ultrasound: pros and cons.
Mary C Mahoney, Mary S Newell. Magn Reson Imaging Clin N Am 2013
10


[Breast cancer screening in high risk populations].
S Alonso Roca, S Jiménez Arranz, A B Delgado Laguna, V Quintana Checa, E Grifol Clar. Radiologia 2012
2

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.
Eveline A M Heijnsdijk, Ellen Warner, Fiona J Gilbert, Madeleine M A Tilanus-Linthorst, Gareth Evans, Petrina A Causer, Rosalind A Eeles, Reinie Kaas, Gerrit Draisma, Elizabeth A Ramsay,[...]. Cancer Epidemiol Biomarkers Prev 2012
51


Practicalities of developing a breast magnetic resonance imaging screening service for women at high risk for breast cancer.
Belinda E Kiely, Lucinda K Hossack, Clair L Shadbolt, Anna Davis, Robin Cassumbhoy, Kate Moodie, Yoland Antill, Gillian Mitchell. ANZ J Surg 2011
3

Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
Christiane Kuhl, Stefanie Weigel, Simone Schrading, Birke Arand, Heribert Bieling, Roy König, Bernd Tombach, Claudia Leutner, Andrea Rieber-Brambs, Dennis Nordhoff,[...]. J Clin Oncol 2010
261

Is there a specific magnetic resonance phenotype characteristic of hereditary breast cancer?
Giovanna Trecate, Siranuosh Manoukian, Laura Suman, Daniele Vergnaghi, Monica Marchesini, Roberto Agresti, Cristina Ferraris, Bernard Peissel, Davide Scaramuzza, Silvana Bergonzi. Tumori 2010
2

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.
Adriana J Rijnsburger, Inge-Marie Obdeijn, Reinoutje Kaas, Madeleine M A Tilanus-Linthorst, Carla Boetes, Claudette E Loo, Martin N J M Wasser, Elisabeth Bergers, Theo Kok, Sara H Muller,[...]. J Clin Oncol 2010
111